Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
2,676,179
-
Total 13F shares
-
836,243
-
Share change
-
+836,211
-
Total reported value
-
$4,898,495
-
Price per share
-
$5.86
-
Number of holders
-
16
-
Value change
-
+$4,898,307
-
Number of buys
-
15
Institutional Holders of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) as of Q3 2025
As of 30 Sep 2025,
NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
836,243 shares.
The largest 10 holders included
Sofinnova Investments, Inc., Affinity Asset Advisors, LLC, Pfizer Inc, VANGUARD GROUP INC, Cable Car Capital, LP, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and Sio Capital Management, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.